French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).

Global stock markets turned lower on Thursday and gold hit a record high as traders fretted over the impact of US President ...

Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy ...

MADISON, Wis. - After becoming the first fire department in the country to test and evaluate a prototype electric fire engine ...

Donations of clothes and money are pouring in for three Detroit-area siblings after authorities found them living alone for ...

U.S. retail sales dropped sharply last month, in part because cold weather kept more Americans indoors, denting sales at car ...

Stock markets diverged and the dollar dipped on Friday as traders tracked US President Donald Trump's latest tariff ...

The average American would drop everything and travel the world if they had $287,731 in the bank. That’s the verdict of a new ...

[ADC12 Price Daily Review] Today, aluminum prices fluctuated slightly. SMM A00 aluminum ingot prices decreased by 30 yuan/mt compared to the previous trading day to 20,510 yuan/mt, while secondary ...